BEONE MEDICINES LTD. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
BEONE MEDICINES LTD. (ONC) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $1.34 billion as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $1.34B.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $1.14B.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $996.59M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $862.21M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration |
|---|---|
| 2025-12-31 | $1.34B 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.14B 10-K · filed 2026-02-26 |
| 2023-12-31 | $996.59M 10-K · filed 2026-02-26 |
| 2022-12-31 | $862.21M 10-K · filed 2025-02-27 |
| 2021-12-31 | $625.11M 10-K · filed 2024-02-26 |
| 2020-12-31 | $358.43M 10-K · filed 2023-02-27 |
| 2019-12-31 | $155.50M 10-K · filed 2022-02-28 |
| 2018-12-31 | $61.27M 10-K · filed 2021-02-25 |
| 2017-12-31 | $29.80M 10-K · filed 2020-03-02 |
| 2016-12-31 | $6.99M 10-K · filed 2019-02-28 |
| 2015-12-31 | $7.15M 10-K · filed 2018-02-28 |